The 301 Hospital or People's Liberation Army General Hospital, which constitutes simultaneously the PLA Postgraduate Medical School, located in Beijing, China, is a military hospital directly subsidiary ...

There are 4,000 beds in The General Hospital of the People's Liberation Army.

During the past decade, The General Hospital of the People's Liberation Army conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 12 clinical trials were completed, i.e. on average, 20.7% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 3 clinical trials were completed. i.e. 13% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The General Hospital of the People's Liberation Army" #1 sponsor was "Chinese PLA General Hospital" with 9 trials, followed by "General Hospital of Chinese Armed Police Forces" with 7 trials sponsored, "Puma Biotechnology, Inc." with 6 trials sponsored, "Peifu Tang" with 4 trials sponsored and "Biotech Pharmaceutical Co., Ltd." with 4 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The General Hospital of the People's Liberation Army" #1 collaborator was "Beijing Anzhen Hospital" with 3 trials as a collaborator, "General Hospital of Chinese Armed Police Forces" with 3 trials as a collaborator, "The First Affiliated Hospital of Zhengzhou University" with 3 trials as a collaborator, "Zhengzhou Cardiovascular Hospital" with 3 trials as a collaborator and "Anyang Regional Hospital" with 2 trials as a collaborator. Other collaborators include 157 different institutions and companies that were collaborators in the rest 134 trials.

According to Clinical.Site data, the most researched conditions in "The General Hospital of the People's Liberation Army" are "Breast Cancer" (7 trials), "Coronary Artery Disease" (5 trials), "Cardiovascular Diseases" (3 trials), "Non-small Cell Lung Cancer" (3 trials) and "Advanced Malignant Solid Tumors" (2 trials). Many other conditions were trialed in "The General Hospital of the People's Liberation Army" in a lesser frequency.

Most popular intervention types in "The General Hospital of the People's Liberation Army" are "Drug" (63 trials), "Device" (14 trials), "Procedure" (11 trials), "Other" (10 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "placebo" (4 trials), "Capecitabine" (3 trials), "Cisplatin" (3 trials) and "Nimotuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "The General Hospital of the People's Liberation Army" are 92 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 20 active trials in "The General Hospital of the People's Liberation Army". 1 are not yet recruiting, 12 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 45 completed trials in The General Hospital of the People's Liberation Army, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in The General Hospital of the People's Liberation Army, 10 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 29 trials that are defined as “Not Applicable".